These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
556 related articles for article (PubMed ID: 32816106)
1. YAP mediates the interaction between the Hippo and PI3K/Akt pathways in mesangial cell proliferation in diabetic nephropathy. Qian X; He L; Hao M; Li Y; Li X; Liu Y; Jiang H; Xu L; Li C; Wu W; Du L; Yin X; Lu Q Acta Diabetol; 2021 Jan; 58(1):47-62. PubMed ID: 32816106 [TBL] [Abstract][Full Text] [Related]
2. Quercetin inhibited mesangial cell proliferation of early diabetic nephropathy through the Hippo pathway. Lei D; Chengcheng L; Xuan Q; Yibing C; Lei W; Hao Y; Xizhi L; Yuan L; Xiaoxing Y; Qian L Pharmacol Res; 2019 Aug; 146():104320. PubMed ID: 31220559 [TBL] [Abstract][Full Text] [Related]
3. LncRNA TUG1 inhibits the proliferation and fibrosis of mesangial cells in diabetic nephropathy via inhibiting the PI3K/AKT pathway. Zang XJ; Li L; Du X; Yang B; Mei CL Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7519-7525. PubMed ID: 31539141 [TBL] [Abstract][Full Text] [Related]
4. Hyperactivation of YAP/TAZ Drives Alterations in Mesangial Cells through Stabilization of N-Myc in Diabetic Nephropathy. Choi S; Hong SP; Bae JH; Suh SH; Bae H; Kang KP; Lee HJ; Koh GY J Am Soc Nephrol; 2023 May; 34(5):809-828. PubMed ID: 36724799 [TBL] [Abstract][Full Text] [Related]
5. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis. Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988 [TBL] [Abstract][Full Text] [Related]
6. Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis. Yang T; Heng C; Zhou Y; Hu Y; Chen S; Wang H; Yang H; Jiang Z; Qian S; Wang Y; Wang J; Zhu X; Du L; Yin X; Lu Q Metabolism; 2020 Jul; 108():154258. PubMed ID: 32376130 [TBL] [Abstract][Full Text] [Related]
7. Sestrin2 attenuates renal damage by regulating Hippo pathway in diabetic nephropathy. Bian Y; Shi C; Song S; Mu L; Wu M; Qiu D; Dong J; Zhang W; Yuan C; Wang D; Zhou Z; Dong X; Shi Y Cell Tissue Res; 2022 Oct; 390(1):93-112. PubMed ID: 35821438 [TBL] [Abstract][Full Text] [Related]
8. XBP1 inhibits mesangial cell apoptosis in response to oxidative stress via the PTEN/AKT pathway in diabetic nephropathy. Wang Y; He Z; Yang Q; Zhou G FEBS Open Bio; 2019 Jul; 9(7):1249-1258. PubMed ID: 31077568 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. Zhang Z; Peng H; Chen J; Chen X; Han F; Xu X; He X; Yan N FEBS Lett; 2009 Jun; 583(12):2009-14. PubMed ID: 19450585 [TBL] [Abstract][Full Text] [Related]
10. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy. Nagai K; Matsubara T; Mima A; Sumi E; Kanamori H; Iehara N; Fukatsu A; Yanagita M; Nakano T; Ishimoto Y; Kita T; Doi T; Arai H Kidney Int; 2005 Aug; 68(2):552-61. PubMed ID: 16014032 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of transcriptional coactivator YAP Impairs the expression and function of transcription factor WT1 in diabetic podocyte injury. Chen J; Wang X; He Q; Yang HC; Fogo AB; Harris RC Kidney Int; 2024 Jun; 105(6):1200-1211. PubMed ID: 38423183 [TBL] [Abstract][Full Text] [Related]
12. AS101 prevents diabetic nephropathy progression and mesangial cell dysfunction: regulation of the AKT downstream pathway. Shemesh II; Rozen-Zvi B; Kalechman Y; Gafter U; Sredni B PLoS One; 2014; 9(12):e114287. PubMed ID: 25474550 [TBL] [Abstract][Full Text] [Related]
13. Hydrophobic motif site-phosphorylated protein kinase CβII between mTORC2 and Akt regulates high glucose-induced mesangial cell hypertrophy. Das F; Ghosh-Choudhury N; Mariappan MM; Kasinath BS; Choudhury GG Am J Physiol Cell Physiol; 2016 Apr; 310(7):C583-96. PubMed ID: 26739493 [TBL] [Abstract][Full Text] [Related]
14. Silencing of PAQR3 suppresses extracellular matrix accumulation in high glucose-stimulated human glomerular mesangial cells via PI3K/AKT signaling pathway. Li H; Wang Y; Chen B; Shi J Eur J Pharmacol; 2018 Aug; 832():50-55. PubMed ID: 29787774 [TBL] [Abstract][Full Text] [Related]
15. FBXW7 mediates high glucose‑induced SREBP‑1 expression in renal tubular cells of diabetic nephropathy under PI3K/Akt pathway regulation. Li L; Yang J; Li F; Gao F; Zhu L; Hao J Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33537812 [TBL] [Abstract][Full Text] [Related]
16. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway. Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149 [TBL] [Abstract][Full Text] [Related]
17. A functional interaction between Hippo-YAP signalling and SREBPs mediates hepatic steatosis in diabetic mice. Shu Z; Gao Y; Zhang G; Zhou Y; Cao J; Wan D; Zhu X; Xiong W J Cell Mol Med; 2019 May; 23(5):3616-3628. PubMed ID: 30821074 [TBL] [Abstract][Full Text] [Related]
18. Ursolic acid attenuates diabetic mesangial cell injury through the up-regulation of autophagy via miRNA-21/PTEN/Akt/mTOR suppression. Lu X; Fan Q; Xu L; Li L; Yue Y; Xu Y; Su Y; Zhang D; Wang L PLoS One; 2015; 10(2):e0117400. PubMed ID: 25689721 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA NEAT1 accelerates the proliferation and fibrosis in diabetic nephropathy through activating Akt/mTOR signaling pathway. Huang S; Xu Y; Ge X; Xu B; Peng W; Jiang X; Shen L; Xia L J Cell Physiol; 2019 Jul; 234(7):11200-11207. PubMed ID: 30515796 [TBL] [Abstract][Full Text] [Related]